PDE4 has also been targeted for various inflammatory conditions, including asthma, COPD, psoriasis, atopic dermatitis, inflammatory bowel diseases, rheumatic arthritis, lupus and neuroinflammation. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.